Acetylcholinesterase inhibitors (AChEIs) and memantine are currently the only anti-dementia drugs (ADDs) approved for treating Alzheimer’s disease (AD) in Italy. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.